The human adiponectin gene has been implicated in the pathophysiology of obesity, type II diabetes mellitus, dyslipidemia and atherosclerosis. Investigation of the physiological functions of the adiponectin gene in humans was mainly conducted at the levels of plasma proteins or DNA polymorphisms. The depot-specific adiponectin mRNA levels also could be relevant to these physiological functions. OBJECTIVES: The relation between the adipose depot-specific adiponectin mRNA expression levels and various metabolic factors, including BMI, fasting plasma glucose, insulin, triglycerides (TGs) and HDL-cholesterol and insulin resistance index by HOMA, was investigated among 66 nondiabetic women using quantitative real-time PCR. RESULTS: The subcutaneous relative adiponectin mRNA levels (SRAmR) correlated significantly with the omental relative adiponectin mRNA levels (ORAmR) (g ¼ 0.468, P ¼ 0.0001). The SRAmR correlated inversely with the fasting plasma glucose with a borderline significance (g ¼ À0.35, P ¼ 0.058). On the other hand, the ORAmR correlated negatively with serum TG levels with the adjustment for age (g ¼ À0.33, P ¼ 0.007) or age plus BMI (g ¼ À0.27, P ¼ 0.027). CONCLUSION: These results indicate that the adiponectin mRNA levels in different adipose depots were at least related to certain phenotypes of metabolic syndrome. The expression levels of adiponectin in the omental adipose depots are related to TG metabolism.
Introduction
Adipose tissue is not only perceived as previously to be an energy storage depot, but is also regarded nowadays as an extremely active endocrine organ. 1 Many biologically active factors, including fatty acids, cytokines and peptides, secreted from adipose tissue may have profound effects on the adipose tissue itself as well as the other tissues of our body. 1, 2 For instance, the adipokine leptin secreted almost solely by adipose tissues acts on the leptin receptors in hypothalamus to regulate satiety as a means to control longterm body adiposity. 2 On the other hand, leptin also affects the physiological functions of adipose tissue itself and those of the others, including fertility and immunity. 3, 4 Recently, another adipokine adiponectin was implicated to play a role in regulating insulin sensitivity and in the pathophysiology of type II diabetes mellitus (DM), dyslipidemia and atherosclerosis in humans. [5] [6] [7] [8] Lower plasma adiponectin levels were associated with obesity, type II DM, dyslipidemia and coronary heart disease (CHD). [5] [6] [7] Human genetic association studies of adiponectin gene polymorphisms with insulin sensitivity, body weight and the risk of type II DM have also been reported. [9] [10] [11] [12] [13] In contrast to the extensive survey at the plasma protein and DNA levels in humans, only a few studies have addressed the physiological relevance of the adiponectin mRNA in adipose tissues primarily because of the difficulty in obtaining adipose tissues for study, especially from the visceral depot. The earliest report from Hu et al 14 showed decreased steady-state mRNA of adiponectin in the adipose tissues from four obese subjects compared to that from three lean subjects. 14 The relative adiponectin mRNA levels were also shown to be lower in the omental adipose tissues of type II DM patients than controls of less than 10 subjects in each group. 15 Recently, it was shown that the adiponectin mRNA levels in the subcutaneous adipose tissue of 22 healthy firstdegree relatives of type II diabetic patients were lower than those in 13 controls. 16 Taken together, these studies suggest that the depot-specific expression of adiponectin at the mRNA level could be relevant to insulin sensitivity, glucose metabolism and body weight control. In this study, we investigated the steady-state adiponectin mRNA levels in both the abdominal subcutaneous and omental adipose tissues from 66 nondiabetic Asian women. We found that the expression levels of adiponectin in different adipose depots are related to various metabolic variables. The expression levels of adiponectin in the omental depots are mainly related to triglyceride (TG) levels.
Subjects and methods
Subjects. We recruited 66 nondiabetic female subjects (by ADA criteria) who underwent elective abdominal surgery (Table 1 ). Both the abdominal subcutaneous and omental adipose tissues were obtained during a scheduled surgery either for benign uterine myoma or for a gastric partition. No specific standard diet was given to the patients during the course of this study. Blood samples were taken the next morning after their admission to the hospital for surgery. Their fasting plasma glucose, insulin, total cholesterol, HDL cholesterol, TG, and the derived insulin resistance index by HOMA were surveyed as previously described. 17 Informed consent was obtained from each patient. This study was approved by the ethical board of National Taiwan University
Hospital. Obesity was defined by BMI X25 kg/m 2 following WHO's recommendation for Asians. 18 Morbid obesity was defined as BMI X40 kg/m 2 . Adipose tissue-RNA extraction and reverse transcription. Adipose tissue was immediately put into liquid nitrogen after resection, and then stored at À801C until used. Total RNA was extracted using REzol (Promega, Madison, WI, USA) according to the manufacturer's instruction. Reverse transcription was performed using a RT kit (Promega, Madison, WI, USA ) with 1 mg of total RNA and 0.5 mg random hexamers in a final volume of 25 ml containing 200 U M-MLV reverse transcriptase, 20 nM/l dNTP, and 25 U rRNasin for 1 h at 371C. The reaction products were diluted to 100 ml with double distilled water before PCR amplification.
Quantitation of mRNA by real-time PCR A 2-ml of diluted cDNA was added to a mixture of 1 Â TaqMan Buffer A, 3.5 mM MgCl 2 plus 0.3 mM dNTP, 4% DMSO, 0.625 U of AmpliTaq Gold (5U/ml, Perkin-Elmer Applied Biosystems, Foster City, CA, USA), and the respective primers for adiponectin, GAPDH and the gene-specific probes to a final volume of 25 ml. The sequences of these primers and genespecific probes were designed by Primer Express soft-ware (Perkin-Elmer Applied Biosystems, Foster City, CA, USA). The primers and the probe for the human adiponectin gene were:
0 reporter dye, TAMRA: 3 0 quencher dye). The primers and the probe for GAPDH were: 5 0 -GAA GGT GAA GGT CGG AGT C-3 0 (forward), 5 0 -GAA GAT GGT GAT GGG ATT TC-3 0 (reverse) and JOE-5 0 -CAA GCT TCC CGT TCT CAG CC-3 0 -TAMRA (probe, JOE: 5 0 reporter dye). Thermocycling conditions were: 2 min at 501C followed by 10 min at 951C and 40 cycles of 15 s at 951C and 1 min at 601C. Real-time quantitative PCR was analyzed by ABI PRISM 7700 Sequence Detection System (TagMan) (Perkin-Elmer Applied Biosystems, Foster City, CA, USA). Fluorescent signal from each PCR reaction is collected as peak-normalized values plotted vs the cycle number. Reactions are characterized by compar- Adiponectin mRNA in adipose depots W-S Yang et al ing threshold cycle (Ct) values. The Ct is a unit-less value defined as the fractional cycle number at which the sample fluorescence signal passes a fixed threshold above baseline. Samples with high starting copy number of cDNA show an increase in fluorescence early in the PCR process, resulting in a low Ct number, whereas those with lower starting copy number results in higher Ct numbers. The comparative Ct method (DCt), which eliminates the need for standard curves, was used (User Bulletin of ABI PRISM 7700 Sequence Detection System). We use the Ct number of GAPDH minus that of adiponectin as a log 2 transform of the adiponectin mRNA expression corrected with GAPDH mRNA expression (DCt). Statistical analysis. Results were expressed as means7s.d., unless indicated otherwise. Student's t-test was used to compare mRNA expression between different groups of subjects. Paired t-test was used to test the difference between two depots from the same subjects. The variables were log transformed if their distribution was skewed. Pearson's correlation and partial correlation were used to examine the correlation between the mRNA levels and the other variables. The statistical analyses were performed using STATA (release 6.0, Stata Corp., College Station, TX, USA).
Results
Among the 66 female subjects, there was no difference in the adiponectin mRNA levels between the subcutaneous and omental adipose depots ( Table 1 ). The omental relative adiponectin mRNA (ORAmR) levels correlated with those in the abdominal subcutaneous adipose tissue significantly (g ¼ 0.468, P ¼ 0.0001, Figure 1a) . The correlation between the ORAmR levels and the subcutaneous relative adiponectin mRNA (SRAmR) levels remained significant after the adjustment for age alone or for age plus BMI ( Table 2 ). The correlation of the relative adiponectin mRNA levels between these two depots remained quite significant within each subgroup categorized by BMI ( Table 2) .
The SRAmR levels negatively correlated only with the fasting plasma glucose (FPG) by a borderline significance without adjustment (g ¼ À0.235, P ¼ 0.058, Figure 1b) . It did not correlate with any other variables, including BMI, insulin, TGs, total cholesterol and HDL-cholesterol (HDL-C) (data not shown). Since obese subjects recruited from the weight reduction surgery tended to be younger, correction for the potential confounding effect of age is critical. The correlation between the SRAmR levels and FPG remained borderlinely significant after the adjustment for age (g ¼ À0.234, P ¼ 0.060) or for age plus BMI (g ¼ À0.228, P ¼ 0.070). In multivariate linear regression, the FPG was also related to the SRAmR levels with a borderline significance (b7s.e. ¼ À0.38470.218, P ¼ 0.084) with adjustment for age, BMI, insulin, TG and HDL-C. These were not observed in the subgroup analysis.
The ORAmR correlated with the FPG with a borderline significance with or without adjustment for BMI and/or age only in the morbidly obese group (data not shown). There was no correlation between the ORAmR and the other variables including BMI, insulin, total cholesterol and The P-values are given in the parentheses.
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The HDL-C correlated with the ORAmR only in the obese or morbidly obese groups without adjustment (data not shown). In multivariate linear regression, fasting serum TG was the only variable related to ORAmR with a borderline significance (b7s.e. ¼ À1.3970.76, P ¼ 0.071) with adjustment for age, BMI, insulin, glucose and HDL-C.
Discussion
The physiological functions of adiponectin in humans have been quite thoroughly investigated at the levels of DNA polymorphisms and plasma protein. [5] [6] [7] [8] [9] [10] [11] [12] [13] However, only three studies have tried to relate the adiponectin mRNA levels to some physiological functions, such as obesity, diabetes and insulin sensitivity. [14] [15] [16] Common to all these mRNA reports was the relatively small sample size and the restricted availability of visceral adipose tissue. In this study, we were able to include 66 female subjects covering a wide range of BMI and examined the adiponectin expression in both the subcutaneous and omental adipose depots. Although the limitation of sample size prevented these mRNA reports from more comprehensive analyses compared with those studies using plasma adiponectin, the value of these studies should not be overlooked. Previously, we found in nondiabetic female subjects that the leptin mRNA levels in the omental depots correlated positively with BMI. 19 In addition, we also measured the resistin mRNA among the subjects in this study (data not shown). We found that the expression levels of resistin mRNA were low compared to those of adiponectin. We did not find any correlation between the resistin expression and the anthropometric and metabolic variables.
The most important finding in this study is that the expression levels of adiponectin in the visceral adipose depot correlated with serum TG levels. It was demonstrated that injection of recombinant adiponectin in mice reduced serum fatty acid levels, which was ascribed to the increased fatty acid b-oxidation in skeletal muscle. 20 Moreover, the increased b-oxidation of fatty acids is secondary to the activation of AMP-activated protein kinase. 21 It is not clear whether adiponectin in the visceral adipose depots may affect fatty acid metabolism. However, it appears to be plausible to speculate that higher adiponectin expression in the visceral adipose tissue may mitigate the spillover of fatty acids into portal vein, thereby reducing the supply of substrate for hepatic VLDL synthesis. In this study, the adiponectin mRNA levels from the subcutaneous and omental adipose depots were significantly correlated. One unit (two-fold) change in the abdominal subcutaneous adiponectin mRNA correlated with only 0.5 U (1.4-fold) change in the omental adiponectin mRNA. This suggests that the omental adiponectin expression may be more tightly regulated than that in the subcutaneous depot.
The finding that the adiponectin expression in the abdominal subcutaneous depot was inversely related to the fasting plasma glucose is quite interesting, although only with a borderline significance. Lihn et al 16 recently also reported a positive correlation between adiponectin mRNA levels in subcutaneous adipose depots and insulin sensitivity in the control group. All together, these studies imply that the subcutaneous adipose depot may not be metabolically naive.
It is well documented that the plasma adiponectin levels were lower in subjects with obesity. 5 However, it is not yet clear whether it is also true for adiponectin mRNA. Hu et al 14 showed lower adiponectin mRNA in the adipose tissue of obese subjects than those of lean subjects. However, the sample size was quite small (four obese vs three lean). Lihn et al 16 found a negative but nonsignificant correlation between adiponectin mRNA levels and BMI. Surprisingly, the adiponectin mRNA levels in either the subcutaneous depots or omental depots were not related to BMI in our study. In fact, we only found a significant negative correlation between ORAmRA and BMI in the morbidly obese subjects after the adjustment of age, and TG levels. One possible explanation is that the hypoadiponectinemia associated with obesity is probably secondary to decreased protein synthesis or secretion. It was demonstrated that insulin stimulation increased adiponectin secretion from cultured adipocytes. 22 Decreased insulin sensitivity in obesity could potentially result in decreased adiponectin secretion. Alternatively, the lack of correlation between adiponectin mRNA and BMI might be attributable to increased insulin resistance during the preparation for a major surgery. However, it cannot be excluded that this was caused by the limitation on the sample size.
In conclusion, the adiponectin mRNA levels in the omental adipose depot are inversely related to the serum TG independent of the other metabolic variables. Whether this is relevant to the dyslipidemia associated with obesity and how this works at the molecular levels merits further investigation. The P-values are given in the parentheses.
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